Oncotarget is a medical journal that publishes articles on topics, such as aging, oncology, immunology, and pathology. Dr. Mikhail Blagosklonny established this journal in 2010. Oncotarget is an open access medical journal that is published by Impact Journals on a weekly basis.
Dr. Mikhail Blagosklonny is a researcher at the Roswell Park Cancer Institute. He is experienced in the field of research, and he has authored numerous articles. His vast background in cancer research, and he has worked as an editor for various journals. Under his management, Oncotarget has received recognition as one of the platforms that relay research findings on time. As the senior editor of Oncotarget, Dr. Mikhail Blagosklonny ensures that authors provide sufficient references to their papers.Oncotarget was initially formed with the aim of publishing cancer reports, but it has since evolved such that it accommodates other topics. Some of the themes include endocrinology, cell biology, and neurology.
Oncotarget is also edited by Andrei V. Gudkov, who is also the founder of this journal. This scientist is involved in handling matters pertaining editing and management of the Oncotaget. He also supervises other junior editors of the journal. Aside from articles, Oncotarget also publishes book chapters and newsletters. Oncotarget’s target audience is mainly scholars and individuals in the field of cancer research. Oncotarget is indexed in the Index Medicus. MEDLINE/Pubmed, Scopus, Science Citation Index Expanded, and BIOSIS Previews. Oncotarget’s mission is mainly to:
- Make known extraordinary scientific discoveries.
- Impact research through insightful review
- Link the different fields of medical sciences
- Encourage the use of clinical sciences to fight life threatening diseases.
- Merge various biomedical fields
Oncotarget works with other associate professors from numerous institutions, including the California Institute of Technology, The Scripps Research Institute, Harvard University, the Institute for Advanced Studies, and John Hopkins University. Oncotarget also works with prominent researchers, such as Arnold Levine, Alexander Vrshavsky, Peter Vogt, and Gregg Semenza. Currently, Oncotarget is doing well, and it has accumulated a higher impact factor in the last couple years. Oncotarget is also listed among the fastest growing open access journals in the United States.